| 1. | chae69933 | |
| 2. | heyjosh | |
| 3. | brianpitkin | |
| 4. | apocalypseangel2 |
Top Board Researchers
These are the top researchers based on quality of posts as voted by board members. Typically they know their stuff and are a great
way to catch up on what the company is all about.
HOW DO I BECOME ONE?
Just do great research! As other members approve of your posts, you earn points that move you up the ranks.| 1. | heyjosh 01/03/2018 Five Prime Therapeutics Submits Investigational New Drug Application for Novel B7-H4 Antibody FPA150 |
| 2. | chae69933 01/25/2018 Five Prime Therapeutics announced that a development milestone for cabiralizumab has been achieved |
| 3. | chae69933 02/28/2018 Yep :) {Image} |
| 4. | chae69933 02/27/2018 Beats EPS loss estimates range from $0.27-$0.36. Misses on revenues. |
| 5. | chae69933 01/23/2018 News out for $FPRX: |
| 6. | chae69933 01/25/2018 Prices upsized underwritten public offering |
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW
Five Prime Therapeutics, Inc.
- FPRX
- Public Stock Message Board
Filtering by:
-
To use your chart in a post, click the
icon above the chart. From there you can get the chart link or download the image.